Presentations

• NEW! Using Adaptive Immune Receptor Repertoire Profiling to Characterize Rare Immune Excluded Tumors (View Now | 13 min)
• Blood Immune Receptor Repertoire and Transcriptome Profiling in a Murine Tuberculosis Model (View Now | 14 min)
• TCR & BCR Repertoire Analysis and Other Approaches for the Discovery of Drug Targets, Resistance Mechanisms and Biomarkers (View Now | 19 min)
• Dissecting the role of T-cell receptors in T-cell large granular lymphocytic leukemias (View Now |  20 min)
• Cellecta Overview (View Now| 17 min)
• Improved Adaptive Immune Receptor Repertoire Profiling for Biomarker Discovery (View Now | 23 min)
• TCR and BCR Repertoire Analysis and Other Approaches for the Discovery of Drug Targets, Resistance Mechanisms and Biomarkers (View Now | 12 min)
• An integrated multi-omics approach to identify molecular regulatory mechanisms in breast cancer development and progression (View Now | 30 min)
• Adaptive Immune Receptor Profiling for Biomarker Discovery (View Now |  19 min)
• A functional map of LncRNAs involved in adaptation pathways of breast cancer cells (View Now | 20 min)
• Perturb-seq analysis of TNFalpha-induced transcriptional response (View Now| 17 min)
• Flexible & Scalable Genetic Screens for Novel Therapeutic Drug Discovery: An Overview of Noteworthy Case Studies (View Now | 48 min)
• Immunophenotyping of TCR and BCR Clonotypes (View Now| 26 min)
• Spatial Transcriptomics: Uses (and Limitations) of a Powerful Technique (View Now | 41 min)
• Network-anchored functional genomics identifies intra-tumoral axes of vulnerability in pancreatic cancer (View Now | 50 mins) 
• Lineage Tracing to Dissect Functional Heterogeneity of Tumor Cells (View Now | 50 mins) 
• CRISPR/Cas9 screens to investigate mechanisms of Cancer Drug Resistance (View Now | 50 mins)
• Critical role of ARID1A in determining the luminal identity and therapeutic response in estrogen receptor positive (ER+) breast cancer (View Now | 25 mins)
• NGS technologies and RNA Expression profiling for Single-Cell Genetic Analysis (View Now | 27 mins)
• Application of DriverMap™Target RNA-Sequencing in Drug Screening (View Now | 20 mins)
• Efficient Tools to Enable Drug Target and Biomarker Discovery: An Introduction to Cellecta Technologies (View Now | 20 mins)
• Customer Presentation: D2G Oncology – Quantitative and Multiplexed in vivo Functional Cancer Genomics Using Barcoded CRISPR Libraries (View Now | 20 mins)
• Assessment of Immune status and Biomarker Discovery using Blood Transcriptomics (View Now | 16 mins)
• Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries (View Now | 55 mins)
• Molecular Snapshot with DriverMap™ Targeted Expression Profiling Assay (View Now | 25 mins) 

Oral Presentations

• DriverMap™: Profiling the Tumor Microenvironment and Biomarkers with CancerNet™, April 2016, AACR Annual Meeting (PDF)
• CRISPR and RNAi Loss-of-Function Genetic Screens, March 2016, MMTC (PowerPoint Slide Show)

For a list of the upcoming events we’re attending, please visit Cellecta’s Events page.